Thrombocytopenia, unspecified. D69.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM D69.6 became effective on October 1, 2019.
Diagnosis Index entries containing back-references to D68.69: Hypercoagulable (state) D68.59 ICD-10-CM Diagnosis Code D68.59. Other primary thrombophilia 2016 2017 2018 2019 Billable/Specific Code Thrombophilia D68.59 ICD-10-CM Diagnosis Code D68.59. Other primary thrombophilia 2016 2017 2018 2019 Billable/Specific Code
A subnormal level of blood platelets. Decrease in the number of blood platelets. ICD-10-CM D69.6 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 813 Coagulation disorders
Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia (a low platelet count), due to the administration of various forms of heparin, an anticoagulant.
Other secondary thrombocytopenia D69. 59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D69. 59 became effective on October 1, 2021.
ICD-10-CM Code for Thrombocytopenia, unspecified D69. 6.
Secondary ITP is known to be caused by systemic autoimmune disorders, primary or secondary immunodeficiency, infectious diseases, paraneoplastic syndromes (e.g., lymphomas and other malignancies), and drug-dependent antibodies (5).
The 2022 edition of ICD-10-CM D61. 810 became effective on October 1, 2021.
Z86. 2 - Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | ICD-10-CM.
Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot. Platelets stop bleeding by clumping and forming plugs in blood vessel injuries.
Secondary thrombocytopenia is similar to primary or idiopathic thrombocytopenia (ITP) in that it is characterized by reduced platelet production or increased platelet destruction resulting in platelet levels<60,000/microL.
Even though the platelet count is elevated for a short time (or even indefinitely after splenectomy), secondary thrombocytosis does not typically lead to abnormal blood clotting. Primary thrombocytosis, or essential thrombocythemia, can cause serious bleeding or clotting complications.
Immune thrombocytopenic purpura (ITP), a condition of low platelets, can occur from primary causes, often referred to as idiopathic thrombocytopenic purpura, or secondary to an underlying disease, such as an autoimmune disorder or an infection.
Chemotherapy-induced thrombocytopenia is a disorder that develops as an adverse effect of chemotherapy. Cancer drugs not only kill cancer cells, they can also damage the platelet-forming cells in the bone marrow. The severity of this disorder depends on the type of chemotherapy and the duration of treatment.
Leucopenia is a condition with too few white blood cells. Low platelet count is called thrombocytopenia. Pancytopenia occurs when a person has a decrease in all three blood cell types. This happens when something is wrong with the bone marrow, where blood cells are formed.
ICD-10-CM Code for Antineoplastic chemotherapy induced pancytopenia D61. 810.
The ICD code D695 is used to code Heparin-induced thrombocytopenia. Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia (a low platelet count), due to the administration of various forms of heparin, an anticoagulant.
HIT predisposes to thrombosis, the abnormal formation of blood clots inside a blood vessel, and when thrombosis is identified the condition is called heparin-induced thrombocytopenia and thrombosis (HITT). HIT is caused by the formation of abnormal antibodies that activate platelets.
Clinical Information. A condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
A decrease in the number of platelets in the blood that may result in easy bruising and excessive bleeding from wound s or bleeding in mucous membranes and other tissues. A finding based on laboratory test results that indicate a decrease in number of platelets in a blood specimen. A subnormal level of blood platelets.